- Review Article
- Endocrinology
- Impact of hematopoietic stem cell transplantation on growth outcomes in mucopolysaccharidosis: a systematic review
-
Farzaneh Abbasi, Asal Khalili Dehkordi, Reihaneh Mohsenipour
-
Clin Exp Pediatr. 2025;68(6):417-427. Published online March 11, 2025
-
|
Hematopoietic stem cell transplantation (HSCT) enhances the growth outcomes of pediatric patients with mucopolysaccharidosis, with early intervention leading to improved height, weight, and body mass index. However, achieving a standard adult height remains uncommon among these patients, even in cases of early HSCT. Growth hormone therapy provides short-term benefits but does not address long-term height deficits. Pubertal development is generally normal; however, precocious puberty and pubertal arrest may occur. |
-
-
|